CTIC Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 birž. 2023 @ 22:58):

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States...

Stats
Dzisiejszy wolumen	5.56M
Średni wolumen	5.66M
Kapitalizacja rynkowa	1.20B
EPS	$0 ( 2024-03-04 )
Następna data zysków	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-16.84
ATR14	$0.183 (2.01%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-26	Bvf Partners L P/il	Sell	43 139	Common Stock, par value $0.001
2023-06-26	Bvf Partners L P/il	Sell	12	Series X Convertible Preferred Stock
2023-06-26	Bvf Partners L P/il	Sell	17	Series X1 Convertible Preferred Stock
2023-06-26	Bvf Partners L P/il	Sell	120 000	Stock Option (Right to Buy)
2023-06-26	Bvf Partners L P/il	Sell	60 000	Stock Option (Right to Buy)

INSIDER POWER
-81.71
Last 99 transactions
Buy: 2 253 317 \| Sell: 15 023 868

Wolumen Korelacja

Długi: 0.20 (neutral)

Krótki: -0.41 (neutral)

Signal:(83.616) Neutral

CTI Biopharma Corp Korelacja

10 Najbardziej pozytywne korelacje
ICPT	0.988
SIGA	0.964
DRNA	0.957
EVLV	0.956
SGTX	0.956
IZEA	0.952
BOXL	0.95
CELH	0.947
TWLVU	0.946
QFIN	0.946

10 Najbardziej negatywne korelacje
TACT	-0.972
LUNA	-0.971
ATAK	-0.968
ITI	-0.951
SBNYP	-0.938
MBIN	-0.937
CPRX	-0.928
VRCA	-0.928
TTCF	-0.927
INOD	-0.922

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CTI Biopharma Corp Korelacja - Waluta/Towar

0.33
( neutral )

0.46
( neutral )

-0.28
( neutral )

-0.02
( neutral )

0.40
( neutral )

CTI Biopharma Corp Finanse

Annual	2022
Przychody:	$53.95M
Zysk brutto:	$50.43M (93.49 %)
EPS:	$-0.790

FY	2022
Przychody:	$53.95M
Zysk brutto:	$50.43M (93.49 %)
EPS:	$-0.790

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.090

FY	2020
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.740

Financial Reports:

No articles found.

CTI Biopharma Corp

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.

Aktualne aktualizacje dla CTI Biopharma Corp [CTIC]

Upcoming Earnings Alert